- Keybanc cut the price target for LyondellBasell Industries N.V. LYB from $85 to $74. Keybanc analyst Aleksey Yefremov maintained an Underweight rating. LyondellBasell shares fell 3.7% to close at $84.16 on Wednesday.
- HC Wainwright & Co. boosted the price target for Aravive, Inc. ARAV from $7 to $12. HC Wainwright & Co. analyst Joseph Pantginis maintained a Buy rating. Aravive shares fell 4.2% to close at $1.61 on Wednesday.
- DA Davidson raised the price target for e.l.f. Beauty, Inc. ELF from $77 to $91. DA Davidson analyst Linda Bolton Weiser maintained a Buy rating. e.l.f. Beauty shares rose 1.8% to close at $73.33 on Wednesday.
- Stifel raised FedEx Corporation FDX price target from $171 to $222. Stifel analyst J. Bruce Chan upgraded the stock from Hold to Buy. FedEx shares rose 2.1% to $199.35 in pre-market trading.
- Telsey Advisory Group cut BRC Inc. BRCC price target from $12 to $10. Telsey Advisory Group analyst Sarang Vora maintained an Outperform rating. BRC shares rose 2.8% to close at $6.17 on Wednesday.
- Citigroup boosted the price target for Netflix, Inc. NFLX from $395 to $400. Citigroup analyst Jason Bazinet maintained a Buy rating on the stock. Netflix shares rose 3% to close at $303.79 on Wednesday.
- JP Morgan boosted Adobe Inc. ADBE price target from $365 to $380. JP Morgan analyst Mark Murphy maintained a Neutral rating. Adobe shares rose 6.1% to $353.82 in pre-market trading.
- Jefferies raised Sportradar Group AG SRAD price target from $10 to $11. Jefferies analyst David Katz maintained a Hold rating. Sportradar shares fell 10.7% to close at $10.50 on Wednesday.
- Wells Fargo raised The Progressive Corporation PGR price target from $116 to $158. Wells Fargo analyst Elyse Greenspan upgraded the stock from Underweight to Overweight. Progressive shares rose 0.6% to $135.87 in pre-market trading.
- Chardan Capital cut Freightos Limited CRGO price target from $13 to $11. Chardan Capital analyst Brian Dobson maintained a Buy rating. Freightos shares fell 1.2% to close at $3.99 on Wednesday.
- Needham cut Esperion Therapeutics, Inc. ESPR price target $16 to $12. Needham analyst Serge Belanger maintained a Buy rating. Esperion Therapeutics shares fell 53% to $1.87 in pre-market trading.
Check This Out: Insiders Selling Micron, KeyCorp And 2 Other Stocks
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in